Biological and clinical significance of epigenetic silencing of MARVELD1 gene in lung cancer

Ming Shi(Harbin Institute of Technology), Yu Li(The University of Texas MD Anderson Cancer Center), Zeyu Wang(Anhui University), Shan Wang(Harbin Institute of Technology), Hao Zhang(Xuzhou Medical College), Yiqun Li(Harbin Institute of Technology), Lei Yue(Chinese Academy of Medical Sciences & Peking Union Medical College), Fang Han(Harbin Institute of Technology), Huan Nie(Harbin Institute of Technology), Jie Su(Harbin Institute of Technology), Jingyan Cao(Harbin Medical University), Yuanfei Yao(Harbin Medical University)
Scientific Reports
December 18, 2014
10.1038/srep07545
Cited by 20

Related Papers

Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer
|Journal of Hepatology|2021|215
Cancer-associated Fibroblast–promoted LncRNA <i>DNM3OS</i> Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma
|Clinical Cancer Research|2018|178